Last reviewed · How we verify

NCT03259243

Comparison of Efficacy of Bupivacaine for Relief Postoperative Pain in Women Undergoing Laparoscopic Gynecologic Surgery

Completed Phase 4 Last updated 22 October 2020
What this trial tests

Phase 4 trial testing Bupivacaine Hydrochloride in Postoperative Pain Score in 100 participants. Completed in 31 January 2018.

Timeline
1 April 2017
Primary endpoint
30 October 2017
31 January 2018

Quick facts

Lead sponsorDepartment of Medical Services Ministry of Public Health of Thailand
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingtriple
Primary purposetreatment
Enrollment100
Start date1 April 2017
Primary completion30 October 2017
Estimated completion31 January 2018
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Department of Medical Services Ministry of Public Health of Thailand

Who can join

Eligibility, female only, with Postoperative Pain Score. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To comparison of efficacy of Bupivacaine for relief postoperative pain in women undergoing laparoscopic gynecologic surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bupivacaine Hydrochloride

Trials testing the same drug.

Other Department of Medical Services Ministry of Public Health of Thailand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03259243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing